BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Specioside

6-O-coumaroylcatalpol [Supplementary Concept] has both analgesic and antidyspeptic activities Heading Mapped to: Iridoid Glucosides

6+ PubMed studies analyzed · Evidence Score: 18.3

Research Domains

Specioside has been studied across 5 research domains including 🔬 Inflammation, 🧘 Stress & Anxiety, ⚡ Energy & Fatigue, ⏳ Longevity & Aging, 🔬 Oncology. The primary research focus is 🔬 Inflammation with 33% of studies addressing this area.

Loading evidence profile...

This evidence profile for Specioside is generated deterministically from 6 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.